Nomura Holdings Inc. acquired a new position in shares of Healthequity Inc (NASDAQ:HQY) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 14,000 shares of the company’s stock, valued at approximately $1,051,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in Healthequity by 11.3% during the second quarter. BlackRock Inc. now owns 7,688,768 shares of the company’s stock worth $577,427,000 after buying an additional 777,915 shares during the last quarter. FMR LLC lifted its stake in shares of Healthequity by 26.5% in the 2nd quarter. FMR LLC now owns 3,410,542 shares of the company’s stock valued at $256,132,000 after purchasing an additional 715,441 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Healthequity by 6.8% in the 1st quarter. JPMorgan Chase & Co. now owns 1,229,111 shares of the company’s stock valued at $74,411,000 after purchasing an additional 78,021 shares during the last quarter. Carillon Tower Advisers Inc. lifted its stake in shares of Healthequity by 751.9% in the 2nd quarter. Carillon Tower Advisers Inc. now owns 752,482 shares of the company’s stock valued at $56,511,000 after purchasing an additional 664,157 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Healthequity by 1.5% in the 1st quarter. Northern Trust Corp now owns 664,085 shares of the company’s stock valued at $40,204,000 after purchasing an additional 9,575 shares during the last quarter. 96.94% of the stock is currently owned by institutional investors.

HQY stock opened at $92.46 on Monday. The firm has a market capitalization of $5.74 billion, a P/E ratio of 171.22, a PEG ratio of 3.21 and a beta of 1.46. Healthequity Inc has a 12-month low of $42.92 and a 12-month high of $99.99.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 4th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.12. The firm had revenue of $71.10 million for the quarter, compared to the consensus estimate of $69.84 million. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The company’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.27 EPS. research analysts forecast that Healthequity Inc will post 0.87 earnings per share for the current fiscal year.

Several equities analysts have recently commented on HQY shares. Bank of America lowered Healthequity from a “buy” rating to a “neutral” rating and upped their price target for the company from $84.00 to $105.00 in a research note on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks upped their price target on Healthequity to $105.00 and gave the company a “buy” rating in a research note on Wednesday, September 5th. Cantor Fitzgerald lowered Healthequity from an “overweight” rating to a “neutral” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 30th. Oppenheimer upped their price target on Healthequity from $68.00 to $85.00 and gave the company an “outperform” rating in a research note on Tuesday, June 5th. Finally, KeyCorp upped their price target on Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a research note on Tuesday, June 5th. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. Healthequity currently has a consensus rating of “Buy” and a consensus price target of $93.08.

In related news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $86.37, for a total value of $345,480.00. Following the sale, the vice president now owns 99,200 shares in the company, valued at approximately $8,567,904. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Medici sold 15,596 shares of the business’s stock in a transaction on Tuesday, July 10th. The shares were sold at an average price of $80.15, for a total value of $1,250,019.40. Following the completion of the sale, the director now owns 26,341 shares in the company, valued at approximately $2,111,231.15. The disclosure for this sale can be found here. Insiders sold a total of 45,500 shares of company stock worth $3,684,201 in the last quarter. Company insiders own 4.00% of the company’s stock.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: Outstanding Shares and The Effect on Share Price

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.